FI70793C - Foerfarande foer framstaellning av en stabil 4'-(9-akridinylamino)metansulfon -m-anisidin(m-amsa)-komposition - Google Patents
Foerfarande foer framstaellning av en stabil 4'-(9-akridinylamino)metansulfon -m-anisidin(m-amsa)-komposition Download PDFInfo
- Publication number
- FI70793C FI70793C FI811474A FI811474A FI70793C FI 70793 C FI70793 C FI 70793C FI 811474 A FI811474 A FI 811474A FI 811474 A FI811474 A FI 811474A FI 70793 C FI70793 C FI 70793C
- Authority
- FI
- Finland
- Prior art keywords
- amsa
- lactic acid
- water
- solution
- acridinylamino
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/147,056 US4360523A (en) | 1980-05-16 | 1980-05-16 | Pharmaceutical formulations of 4'-(9-acridinylamino)-methanesulfon-m-anisidide |
US14705680 | 1980-05-16 |
Publications (3)
Publication Number | Publication Date |
---|---|
FI811474L FI811474L (fi) | 1981-11-17 |
FI70793B FI70793B (fi) | 1986-07-18 |
FI70793C true FI70793C (fi) | 1986-10-27 |
Family
ID=22520148
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI811474A FI70793C (fi) | 1980-05-16 | 1981-05-13 | Foerfarande foer framstaellning av en stabil 4'-(9-akridinylamino)metansulfon -m-anisidin(m-amsa)-komposition |
Country Status (21)
Country | Link |
---|---|
US (1) | US4360523A (da) |
JP (1) | JPS579716A (da) |
AT (1) | AT374682B (da) |
AU (1) | AU543726B2 (da) |
BE (1) | BE888832A (da) |
CA (1) | CA1160571A (da) |
CH (1) | CH647677A5 (da) |
DE (1) | DE3119510A1 (da) |
DK (1) | DK159376C (da) |
FI (1) | FI70793C (da) |
FR (1) | FR2482458A1 (da) |
GB (1) | GB2076288B (da) |
GR (1) | GR75658B (da) |
IE (1) | IE51285B1 (da) |
IT (1) | IT1170970B (da) |
LU (1) | LU83363A1 (da) |
NL (1) | NL8102362A (da) |
NZ (1) | NZ196985A (da) |
SE (1) | SE460457B (da) |
YU (1) | YU44831B (da) |
ZA (1) | ZA813188B (da) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4575509A (en) * | 1983-01-31 | 1986-03-11 | Bristol-Myers Company | Water-soluble formulations of m-AMSA with pyroglutamic acid |
US4626541A (en) * | 1985-09-12 | 1986-12-02 | Bristol-Myers Company | Water soluble salt composition of m-AMSA |
DE3819842C1 (da) * | 1988-03-23 | 1989-12-21 | Karl Heinz Dr. 7100 Heilbronn De Thiel | |
DE3844518A1 (de) * | 1988-03-23 | 1989-10-05 | Karl Heinz Dr Med Thiel | Verwendung von aminochinolinen und aminopyridinen zur iontophoretischen behandlung maligner tumore |
CA2143515A1 (en) * | 1994-03-22 | 1995-09-23 | Prakash Parab | Method for enhancing the rate of skin permeation of lactic acid through use of the l-enantiomer |
DE102004031538A1 (de) * | 2004-06-29 | 2006-02-09 | Baxter International Inc., Deerfield | Pharmazeutische Darreichungsform zur oralen Verabreichung eines schwerlöslichen Wirkstoffs, Verfahren zu deren Herstellung und Kit |
WO2006002887A1 (en) * | 2004-06-29 | 2006-01-12 | Baxter International Inc. | Aqueous drink solution of indibulin (d-24851) and an organic acid |
BRPI0517652A (pt) * | 2004-11-08 | 2008-10-14 | Baxter Healthcare Sa | composições farmacêuticas nanoparticuladas de inibidores de tubulina, métodos para as suas preparações e respectivos usos |
US20080241274A1 (en) * | 2006-11-28 | 2008-10-02 | Ziopharm Oncology, Inc. | Indibulin therapy |
WO2015150383A1 (en) * | 2014-03-31 | 2015-10-08 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Glycolic acid and/or d-lactic acid for the treatment of neurodegenerative diseases |
-
1980
- 1980-05-16 US US06/147,056 patent/US4360523A/en not_active Expired - Lifetime
-
1981
- 1981-04-27 CA CA000376348A patent/CA1160571A/en not_active Expired
- 1981-04-30 YU YU1123/81A patent/YU44831B/xx unknown
- 1981-05-01 NZ NZ196985A patent/NZ196985A/xx unknown
- 1981-05-06 GR GR64859A patent/GR75658B/el unknown
- 1981-05-08 AU AU70291/81A patent/AU543726B2/en not_active Ceased
- 1981-05-13 NL NL8102362A patent/NL8102362A/nl not_active Application Discontinuation
- 1981-05-13 FI FI811474A patent/FI70793C/fi not_active IP Right Cessation
- 1981-05-13 ZA ZA00813188A patent/ZA813188B/xx unknown
- 1981-05-13 FR FR8109497A patent/FR2482458A1/fr active Granted
- 1981-05-14 IT IT48467/81A patent/IT1170970B/it active
- 1981-05-14 DK DK216681A patent/DK159376C/da active
- 1981-05-15 DE DE19813119510 patent/DE3119510A1/de active Granted
- 1981-05-15 GB GB8114947A patent/GB2076288B/en not_active Expired
- 1981-05-15 IE IE1092/81A patent/IE51285B1/en unknown
- 1981-05-15 LU LU83363A patent/LU83363A1/fr unknown
- 1981-05-15 BE BE0/204812A patent/BE888832A/fr not_active IP Right Cessation
- 1981-05-15 SE SE8103071A patent/SE460457B/sv not_active IP Right Cessation
- 1981-05-15 JP JP7239381A patent/JPS579716A/ja active Granted
- 1981-05-15 CH CH3195/81A patent/CH647677A5/de not_active IP Right Cessation
- 1981-05-18 AT AT0221181A patent/AT374682B/de active
Also Published As
Publication number | Publication date |
---|---|
DK159376C (da) | 1991-03-25 |
FR2482458B1 (da) | 1984-12-14 |
JPH0136445B2 (da) | 1989-07-31 |
AT374682B (de) | 1984-05-25 |
IT1170970B (it) | 1987-06-03 |
NL8102362A (nl) | 1981-12-16 |
IE811092L (en) | 1981-11-16 |
YU44831B (en) | 1991-04-30 |
CA1160571A (en) | 1984-01-17 |
GB2076288B (en) | 1983-12-14 |
SE460457B (sv) | 1989-10-16 |
IE51285B1 (en) | 1986-11-26 |
ZA813188B (en) | 1982-05-26 |
DE3119510A1 (de) | 1982-02-25 |
JPS579716A (en) | 1982-01-19 |
NZ196985A (en) | 1983-06-17 |
LU83363A1 (fr) | 1982-01-20 |
FI70793B (fi) | 1986-07-18 |
DK216681A (da) | 1981-11-17 |
FR2482458A1 (fr) | 1981-11-20 |
CH647677A5 (de) | 1985-02-15 |
AU543726B2 (en) | 1985-05-02 |
FI811474L (fi) | 1981-11-17 |
DK159376B (da) | 1990-10-08 |
SE8103071L (sv) | 1981-11-17 |
DE3119510C2 (da) | 1991-03-07 |
YU112381A (en) | 1985-03-20 |
GR75658B (da) | 1984-08-02 |
GB2076288A (en) | 1981-12-02 |
AU7029181A (en) | 1981-11-19 |
ATA221181A (de) | 1983-10-15 |
US4360523A (en) | 1982-11-23 |
IT8148467A0 (it) | 1981-05-14 |
BE888832A (fr) | 1981-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6987108B2 (en) | Pharmaceutical formulations of antineoplastic agents and processes of making and using the same | |
US6780881B2 (en) | Freeze-dried pantoprazole preparation and pantoprazole injection | |
FI109659B (fi) | Levosimendaanin farmaseuttisia liuoksia | |
FI70793C (fi) | Foerfarande foer framstaellning av en stabil 4'-(9-akridinylamino)metansulfon -m-anisidin(m-amsa)-komposition | |
CA1302278C (en) | Injection solutions of torasemide which are ready to use and processes for their preparation thereof | |
US5942510A (en) | Pharmaceutical composition containing lamotrigine | |
US5750131A (en) | Ifosfamide lyophilizate preparations | |
US4425348A (en) | Antitumor compositions | |
EP0682522B1 (en) | Process to prepare pharmaceutical compositions containing vecuronium bromide | |
JPH0343251B2 (da) | ||
FI80023B (fi) | Sammansaettningar, som verkar foerstoerande pao tumoerer. | |
US4322424A (en) | Crystalline glucoconate salt of m-AMSA and compositions containing same | |
US4626541A (en) | Water soluble salt composition of m-AMSA | |
US20080096947A1 (en) | Parenteral Forms Of Administration Of Imexon And Method For The Production Thereof | |
EP1508332A1 (en) | Medicinal composition | |
CA1159368A (en) | Antitumor compositions | |
AU2006235847C1 (en) | Lyophilized pantoprazole preparation | |
JPH032862B2 (da) | ||
WIRKSTOFFEN et al. | TEMOZOLOMIDE, PROCESSES OF MAKING AND USING THE SAME |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM | Patent lapsed |
Owner name: BRISTOL-MYERS CO |